Our Team

Entrepreneurial and intuitive, Miriam founded mdgroup in 2002. Today, mdgroup is a global digital and patient health services business delivering highly personalised solutions that support clinical trials worldwide.

As CEO, Miriam brings deep industry expertise and a clear vision for putting patients first. She has built a culture where patient needs guide every decision, ensuring teams deliver high-quality, care-led services that improve both patient experience and trial outcomes.

Miriam is equally committed to supporting the success of others. As Chair of Women in Business for the European Council of WEConnect Europe, she champions women-led enterprise, education, and networking, and shares her personal journey—from school-leaver to founder—to inspire the next generation of entrepreneurs.

Peter is a distinguished senior life sciences executive with over 25 years of comprehensive experience. He has a proven track record of leading global teams within sponsor organisations and contract research organisations (CROs).

Recognised as a PharmaVoice Top 100 leader, Peter is renowned for fostering highly effective collaborations between sponsors, CROs, investigator sites, and patient advocacy groups. His commitment to advancing research is further demonstrated through his roles on councils and advisory boards supporting Parkinson’s disease research and policy initiatives.

Based in Paris since 2019, Peter brings a wealth of international expertise to the teams he leads, enhancing global perspectives and operational excellence.

With over 20 years of experience in global drug development, Ian brings invaluable insight to our board as a Non-Executive Director. His expertise spans biotech, pharma, CROs, and health-tech sectors, with a strong track record in delivering patient-focused solutions across multiple therapeutic areas, including rare diseases, oncology, and respiratory conditions. He has successfully guided drug development from pre-IND through phase IV across the US, Europe, and Japan.

A PhD scientist with deep operational and regulatory expertise, Ian excels at translating complex challenges into actionable strategies. His leadership spans CMC, clinical operations, quality, and project management, ensuring success at every stage of development. Having worked closely with mdgroup as a client, Ian brings a unique perspective that allows him to think creatively about our products and services, identifying opportunities for innovation and growth.

With a passion for advancing health-tech solutions, Ian is committed to helping organisations expand their market share, enhance their offerings, and drive meaningful change in drug development and clinical research.

Scott is a versatile leader with a strong track record of delivering innovative product and market strategies in the life sciences and healthcare software sectors. With a solid understanding of clinical, technological, and business fundamentals, he’s passionate about creating breakthrough solutions that meet the evolving needs of the industry.

He has extensive experience in the clinical development process, specialising in late-phase trials, post-market surveillance, and direct-to-patient initiatives. Scott is also highly knowledgeable in M2M (machine-to-machine) solutions for the life sciences, pharmaceutical, and healthcare markets. His results-driven approach blends sales and operational planning with agile methods for new product development.

Throughout his career, Scott has worked with organisations ranging from start-ups to global Fortune 100 companies, building expertise in sales, marketing, operations, and product strategy. He’s passionate about aligning product development with strategic goals and spotting opportunities to drive meaningful results.

Ian came to his position as Financial Director with a wealth of experience. He qualified as a Fellow Member of the Association of Chartered Certified Accountants in practice and has held senior financial roles in FTSE 100 companies around the world including GSK, Vodafone and K3 business technologies, a key partner for Microsoft.

Having been involved in large scale company growth during his career, Ian has implemented various accounting systems on a global level, reporting to financial compliance bodies where he has worked in the UK, North America and Europe.

Ian drives our corporate performance and profitability, maintaining the highest quality reporting across our global enterprise. He’s passionate about the mdgroup commitment to delivering remarkable results for our clients and takes a dynamic, strategic approach to mdgroup product development and innovation, keeping us at the forefront of the clinical research industry.